Share on StockTwits

Edap Tms SA (NASDAQ:EDAP) was the target of a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 647,824 shares, a decrease of 54.8% from the July 31st total of 1,433,149 shares, Stock Ratings reports. Based on an average trading volume of 925,889 shares, the short-interest ratio is currently 0.7 days. Currently, 0.0% of the shares of the company are sold short.

EDAP has been the subject of a number of recent research reports. Analysts at Northland Securities cut their price target on shares of Edap Tms SA to $2.00 in a research note on Thursday, July 31st. Finally, analysts at HC Wainwright initiated coverage on shares of Edap Tms SA in a research note on Monday, June 16th. They set a “buy” rating and a $6.00 price target on the stock.

Shares of Edap Tms SA (NASDAQ:EDAP) opened at 1.55 on Thursday. Edap Tms SA has a one year low of $1.38 and a one year high of $6.05. The stock has a 50-day moving average of $2.61 and a 200-day moving average of $3.34. The company’s market cap is $33.8 million.

Edap Tms SA (NASDAQ:EDAP) last announced its earnings results on Thursday, August 28th. The company reported ($0.32) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.04) by $0.28. The company had revenue of $7.70 million for the quarter, compared to the consensus estimate of $10.32 million. During the same quarter in the prior year, the company posted ($0.27) earnings per share. On average, analysts predict that Edap Tms SA will post $-0.12 earnings per share for the current fiscal year.

Edap Tms SA (NASDAQ:EDAP) is engaged in developing and marketing the Ablatherm device, an advanced choice for high intensity focused ultrasound (HIFU) treatment of localized prostate cancer.

Receive News & Ratings for Edap Tms SA (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms SA (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.